David Soergel

All filings by David Soergel on record concern Madrigal Pharmaceuticals, Inc. The record holds 2 filings, for trades running from 15 May 2025 to 4 March 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Most recently, on 6 March 2026, the filings show a share grant in Madrigal Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.